# Seagen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seagen

- Industry: Pharmaceuticals
- Headquarters: Bothell, US
- Total disclosed funding: $30M
- Latest round: Series B (Mar 14, 2000)
- Investors on record: 6

## About

Founded in 1998 and based in Washington, US, Seagen Inc. formerly known as Seattle Genetics, Inc. is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.

## Funding rounds

- Series B, Mar 14, 2000, $30M — OVP Venture Partners, Sofinnova Investments, Cascade Investment, Scale Venture Partners, Vulcan, Indosuez Ventures

## Investors

- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series B
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B
- Cascade Investment — Series B
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series B
- Vulcan (https://capitalatlas.ai/funds/vulcan) — Series B
- Indosuez Ventures (https://capitalatlas.ai/funds/indosuez-ventures) — Series B